Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 40,000 shares at $74.01 ($3.0M) on 2020-04-30, disclosed to the SEC on 2020-05-01.
Seasonal sale ($3.0M) by Chairman — this insider has traded EBS in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.24 | 20,000 | $1.5M | 50.1% |
| 2 | $74.01 | 20,000 | $1.5M | 49.9% |
| Total | $74.13 avg | 40,000 | $3.0M | 100% |
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |